10X GENOMICS Stock (TXG.re) Price Chart, Analysis, and Forecast

View the real-time 10X GENOMICS (TXG.re) stock quote and decide if you want to buy and when to sell. Find predictions, financials, the latest news and other information to help you with your stock investing.

$51.56
-9.88%
100.00% buyers
Followers
106
Annual change
173.96%
Daily price range:
Low
51.28
High
55.75
Trade TXG

All investing involves risk

TXG live price

Live Chart

Past performance is not a reliable indicator of future results.

Is 10X GENOMICS a good stock to buy?

The quantitative stock rating system created by TipRanks shows that 10X GENOMICS price is underperforming. Its Smart Score¹ of 2 indicates 10X GENOMICS is not one of the best stocks to buy now.

2

Smart Score

Why is 10X GENOMICS stock price going up?

10X GENOMICS

Bulls say

  • Product adoption

    Widespread orders and use of the Atera system by prominent research institutions and major biopharma companies indicate strong commercial interest that could scale the platform's revenue.

  • Consumables & recurring revenue

    Consistent beats in Spatial Biology and Chromium consumables, along with indications of higher consumables per Atera instrument, point to growing recurring revenue that supports revenue stability.

  • Product roadmap expansion

    An expanded roadmap that adds whole‑transcriptome profiling, automation, multiomics, and targeted mutation detection broadens application use cases and can increase the company's addressable market.

  • Instrument cannibalization

    Transition to the Atera platform is reducing demand for existing spatial instruments, which may depress instrument revenue as customers replace legacy systems.

  • Valuation pressure

    Broader peer de‑rating and cautious analyst adjustments have lowered the valuation multiple, which could weigh on the stock despite operational improvements.

  • Customer adoption uncertainty

    Unclear distinction between net new Atera-driven business and replacements, together with limited direct insight from pharmaceutical customers, creates uncertainty about the durability of revenue expansion.

Why is 10X GENOMICS stock price going down?

10X GENOMICS

Bears say

    No bearish insights available yet.

What is happening with
10X GENOMICS stock price today?

  • The price of 10X GENOMICS today, as of November 20, 2026, was $51.56. That's down -9.88% from the previous session's 10X GENOMICS closing price.

  • The 10X GENOMICS price is declining this week. Compared to last week, the rate of 10X GENOMICS is down -5.50%, and it's down -27.60% from one month ago.

  • The 52-week 10X GENOMICS price high is $102.20, while the 52-week 10X GENOMICS price low is $15.18.

  • Year to date, 10X GENOMICS price is up 184.50% from the beginning of the year and has had a return of 184.50% in the last 12 months.

What is the sentiment of 10X GENOMICS stock in noviembre 2026?

The sentiment score², indicating how the crowd feels about 10X GENOMICS stock is NEGATIVE. The sentiment signal³ observed at the start of the market session, offering insights into whether 10X GENOMICS stock price today is likely to increase, decrease, or remain steady, is BEARISH.

News Sentiment
Neutral
Neutral
Bullish: --Bearish: --
Blogger Opinion
Neutral
Neutral
Bullish: 42%Bearish: 58%
Investors Sentiment
Very Negative
Very Negative
Past 7d: -2%Past 30d: -16%

Table with the sentiment of 10X GENOMICS stock in noviembre 2026

10X GENOMICS stock analysis

Based on analysts giving ratings to 10X GENOMICS stock, the consensus⁴ is BUY. Hedge funds activity⁵ decreased in the last quarter, while Insider activity⁶ trend is bearish (sold 10X GENOMICS shares)

10X GENOMICS Technical Analysis

Trending upPositive
SMA
Trending up2.15
Momentum

Simple moving average: 20/200 days

Momentum: 12 month change

10X GENOMICS Insider Activity

Trending downsold shares
Trend

Net -6.3M shares last quarter

10X GENOMICS Fundamentals

Trending down-8.0%
Return on equity
Trending up+3.0%
Asset Growth

Return on equity: last 12 months

Asset growth: 12 month change

Discover key 10X GENOMICS stock trends with NAGA Insights

What am I Missing?

  • Make informed decisions based on real-time data, expert analysis, and powerful research tools from TipRanks.

  • Access advanced 10X GENOMICS charting, technical analysis, and live market data from TradingView.

  • Get AI-powered 10X GENOMICS trade signals, in-depth market analysis, and technical strategy insights from Trading Central.

All investing involves risk

Best Stocks Discover

10X GENOMICS stock outlook 2026

Analysts forecast 10X GENOMICS stock price will rise in the next 12 months. Based on 15 Wall Street analysts offering 10X GENOMICS price predictions in the last 3 months, the average price target is $74.15.

The highest 10X GENOMICS stock forecast is $110.00, while the lowest is $55.00. The average 10X GENOMICS price target represents a 43.15% change from the actual price of $51.56.

10X GENOMICS stock price prediction⁷

  • Highest price target$110.00
  • Average price target$74.15
  • Lowest price target$55.00

10X GENOMICS stock forecast⁸

  • Buy33.33%
  • Hold66.67%
  • Sell0.00%

Overview of stock forecast and price predictions 2026. Analyst price targets and consensus are estimates only and do not constitute guarantees of future outcomes.

Investing in 10X GENOMICS stock

There are two ways to invest in 10X GENOMICS stock: trading 10X GENOMICS stock through derivatives like CFDs or buying shares of 10X GENOMICS stock outright. With NAGA.com, you can do both and more.


Buy 10X GENOMICS shares of stock if you want to hold them for a long time. You commit the full value of the 10X GENOMICS shares outright and profit only if they increase in price.


Trade 10X GENOMICS if you want more flexibility — say you want to speculate on its price movements in both directions. With CFDs, you can open a buy position (go long) if you think 10X GENOMICS stock’s price will rise, or you can open a sell position (go short) if you believe the 10X GENOMICS stock’s price will fall.


You won’t need to commit to the full value of the position. But bear in mind that leverage can increase both your profits and losses.

How to invest

How to trade 10X GENOMICS with CFDs?

  • If you want to speculate on 10X GENOMICS price, search for 10X GENOMICS CFD. Then click on the "10X GENOMICS" symbol to view the chart and other insights before placing your trade. Also, review "10X GENOMICS" contract specification to be aware of all the 10X GENOMICS CFD trading conditions.

How to buy 10X GENOMICS stock?

  • If you want to buy 10X GENOMICS shares outright to hold them for a long time, search for 10X GENOMICS stock with ownership (Real Stocks). Then click on the "10X GENOMICS" symbol to view the chart and other insights before placing your trade. Also, review "10X GENOMICS" contract specification to be aware of all the 10X GENOMICS stock buying conditions.

trading conditions:

Platform
MT5
Ticker#TXG.re
Volume step
Lot value
Minimum trade size
Maximum trade size
Commission0.00%
Monthly price change (%)-26.24%
Annual price change (%)173.96%
Digits
Tick value0.009
Trading Hours & Fees

All investing involves risk

10X GENOMICS company presentation

TXG

10X Genomics

Real Stocks

-9.88%

$51.61
$51.56

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

Latest 10X GENOMICS stock news

Discover the latest news that can influence 10X GENOMICS’s earnings sentiment and 10X GENOMICS forecast and price predictions.

Neutral
ACHR, LUNR, TXG: Cathie Wood Sells $6.1M of One Growth Stock, Buys the Other Two
18/11/2026/12:24
Neutral
10x Genomics announces two new research collaborations
16/11/2026/16:15
Neutral
10x Genomics' Xenium Platform to Support Breast Cancer Biomarker Study
12/11/2026/12:27

FAQs about 10X GENOMICS trading

The price of 10X GENOMICS stock today, as of November 20, 2026, was 51.56. That's down -9.88% from the previous session's 10X GENOMICS closing price.

IMPORTANT NOTICE: The content presented in the instrument page is only for informational, educational and support purposes. The material presented, including analyses, sentiment, consensus, prices, opinions or other content, is not an investment recommendation or information that recommends or suggests an investment strategy, nor is it included in the scope of investment advice. NAGA will not accept liability for any loss or damage, including but not limited to any loss of profits, that may arise directly or indirectly from the use of or reliance on the information contained in this page. NAGA is not responsible for the actions or omissions of the client, especially for the acquisition or disposal of financial instruments, made based on the information contained in this page. Past performance is not necessarily indicative of future results, and anyone acting on this information does so at their own risk. ¹ ⁵ ⁶ The Smart Score is a proprietary quantitative stock scoring system created by TipRanks. It assigns stocks a score from one to ten, based on 8 market key factors. The lowest score is 1, and the highest is 10. Stocks with a score of 8, 9, or 10 are considered Outperform, and with a score of 1, 2, or 3 are considered Underperform. The score is data-driven and does not involve any human intervention. The contributing market factors are Wall Street analyst ratings, Corporate insider transactions, Financial blogger opinions, Individual investor sentiment, Hedge fund manager activity, News sentiment, Technicals and Fundamentals. This information is provided for indicative purposes only and should not be interpreted as investment advice or a recommendation to trade. ⁴ ⁷ ⁸ TipRanks’ consensus ratings provide an aggregated view of expectations and consensus on a particular stock from a wide range of global analyst opinions. They’re then condensed into a single indicator, which can help you make investment decisions based on expert analysis. TipRanks’ 12-month forecast is a consensus price target derived from Wall Street analysts’ projections made over the past three months. It forecasts the potential high, low, and average share price for a stock one year from now, along with the average expected upside or downside percentage. ² ³ The sentiment signal and sentiment score are provided by Trading Central. Sentiment insights and market views are based on available data and do not guarantee future performance.